Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Enrollment completed in phase III study of Cerepro

April 25, 2007

Pharmion advances oral azacitidine in phase I

April 25, 2007

SuperGen to sell mitomycin and paclitaxel to Intas

April 24, 2007

MKC-1 disrupts microtubules and multiple survival pathways in hematological cancers

April 24, 2007

CBLB-612 demonstrates efficacy in primate study

April 24, 2007

Antisoma and Novartis sign global licensing agreement for AS-1404

April 24, 2007

Preclinical development of AT-13387, an HSP90 inhibitor, proceeds towards IND filing

April 24, 2007

Dual FAK/Pyk2 kinase inhibitor displays promising preclinical profile

April 24, 2007

Preclinical data reported for new irofulven analogue MGI-4184

April 24, 2007

Sirtex Medical to sponsor FAST trial

April 24, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....